Vaxcyte, Inc. (PCVX) SEC Filings — 2024
19 SEC filings for Vaxcyte, Inc. (PCVX) in 2024.
Filings
- Vaxcyte Amends Credit Agreement with OrbiMed — 8-K · Nov 21, 2024
- Vaxcyte, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Vaxcyte, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Vaxcyte, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Vaxcyte, Inc. Files Q3 2024 10-Q Report — 10-Q · Nov 5, 2024
- Vaxcyte Files 8-K: Other Events & Exhibits — 8-K · Sep 6, 2024
- Vaxcyte, Inc. Files 8-K Report — 8-K · Sep 3, 2024
- Vaxcyte, Inc. Files Q2 2024 10-Q Report — 10-Q · Aug 6, 2024
- Vaxcyte Appoints New CMO, CDO; Adds Director — 8-K · Jul 2, 2024
- Vaxcyte, Inc. Reports on Security Holder Meeting — 8-K · Jun 10, 2024
- Vaxcyte, Inc. Files 10-Q for Q1 2024 — 10-Q · May 8, 2024
- Vaxcyte, Inc. DEF 14A Filing — DEF 14A · Apr 15, 2024
- Vaxcyte, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 27, 2024
- Vaxcyte, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Vaxcyte, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Vaxcyte, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- FMR LLC & Abigail Johnson Hold 14.94% Stake in Vaxcyte — SC 13G/A · Feb 9, 2024
- Vaxcyte Files Routine 8-K, Confirms Registration Details — 8-K · Jan 31, 2024
- BlackRock Amends Vaxcyte Stake, Maintains Passive Investment — SC 13G/A · Jan 25, 2024